Home/Investors/Invus

Invus

Biotech Investor · 6 portfolio companies

Portfolio

6

Focus Areas

7

Top Stage

preclinical

Investment Focus

Schizophrenia HIV Prevention Opioid Use Disorder Chronic Disease Oncology Neuroscience Immunology

Portfolio Companies

Company	Stage	Valuation	Focus
Lyndra	Phase 3	—	Schizophrenia, HIV Prevention
Engine Biosciences	Pre-clinical	—	Oncology
Nido Biosciences	preclinical	—	Neuroscience, Immunology
NextPoint Therapeutics	preclinical	—	Oncology, Immunology
Flare Therapeutics	preclinical	—	Oncology, Neuroscience
LifeMine Therapeutics	preclinical	—	Oncology, Immunology

Frequent Co-Investors

Polaris Partners3 shared 5AM Ventures1 shared ARCH Venture Partners1 shared GV1 shared Boxer Capital1 shared MPM Capital1 shared Access Biotechnology1 shared Third Rock Ventures1 shared